Amgen Inc has made an agreed bid for privately-owned BioVex Group Inc of the US of which has a therapeutic cancer vaccine in late clinical development against metastatic melanoma and head and neck cancer. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
